University of Michigan rheumatologist Daniel Clauw, M.D., on the potential benefits and risks of using cannabinoids to treat chronic pain. (©JanMika/Shutterstock.com)
Fibromyalgia Tied to Chronic Migraines
The frequency is significantly higher than in patients with chronic tension-type headaches and the symptoms are more severe.
New Pain Management Strategies Spelled Out
National initiatives are designed to provide education, advance research, solve the opioid crisis, and help patients.
Break From Methotrexate Boosts Flu Shot Efficacy in RA
With a drug holiday, patients with rheumatoid arthritis could improve their response to influenza vaccinations without increasing disease activity.
In RA, No Added Second Malignancy Risk With Biologics
Some physicians have shown reluctance to use these agents for patients who have rheumatoid arthritis and a previous cancer diagnosis.
How Cannabis Might Treat Rheumatic Diseases
The role of legalized marijuana in society and evidence-based medicine was examined at the ACR/ARHP Annual Meeting.
Biologic Use in Pregnancy Does Not Increase Infant Infection Risk
New evidence is reassuring for women with rheumatoid arthritis who need treatment with a biologic throughout pregnancy.
Stopping Bisphosphonates Ups Hip Fracture Risk
Study findings may help guide rheumatologists plan long-term therapy for patients dealing with low bone mass.
Fitness Interventions for Rheumatologic Fatigue and Pain
The ACR/ARHP Annual Meeting provided a research update on surrounding issues and strategies for helping patients.
In Lupus, Low Vitamin D Means High Renal Disease Risk
There’s a higher risk of total organ damage and end-stage renal disease in patients with SLE.
Biosimilars: To Switch or Not to Switch?
The pros and cons of using biosimilar medications shaped the “Great Debate” at this year’s ACR/ARHP Annual Meeting.